Indamid Sr (Indapamide)

Indapamide inhibits the Na⁺/Cl⁻ cotransporter in the distal convoluted tubule of the kidney, reducing sodium and chloride reabsorption. This leads to increased urinary excretion of water and electrolytes, decreasing plasma volume and peripheral vascular resistance, which together lower blood pressure and alleviate edema.

The dosage of indapamide is individualized by the prescribing clinician based on the patient’s condition, renal function, and response to therapy. Typical adult regimens range from 1.5 mg to 2.5 mg once daily, but exact dosing must be determined by a qualified healthcare provider.

Safety data for indapamide in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by the prescriber in consultation with the patient. Breastfeeding mothers should discuss alternatives with their doctor.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Indamid Sr. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Indapamide is a thiazide‑like diuretic that offers a longer duration of action and a lower incidence of metabolic side effects such as hypokalemia compared with traditional thiazide diuretics like hydrochlorothiazide. It is often chosen when clinicians need effective blood‑pressure control with a favorable electrolyte profile.

Indamid Sr should be stored at ambient temperature, preferably below 25 °C, in its original packaging. Protect the product from moisture, excessive heat and direct sunlight to maintain its stability and potency throughout its shelf life.

Indamid Sr is taken orally, usually once daily in the morning, with or without food as directed by the prescriber. Swallow the tablet whole with a full glass of water and follow any specific instructions regarding timing relative to other medications.

Serious adverse events, although uncommon, include severe electrolyte disturbances such as hyponatremia or hypokalemia, acute renal failure, and hypersensitivity reactions that may present as rash, angioedema or anaphylaxis. Patients should seek immediate medical attention if they experience symptoms like muscle weakness, irregular heartbeat, severe dizziness, or swelling of the face and throat.

Indapamide is contraindicated in patients with known hypersensitivity to indapamide or other sulfonamide‑derived drugs, and should be used with caution in individuals with severe renal impairment, uncontrolled diabetes, gout, or those taking lithium. Pregnant or breastfeeding women should only use it when clearly indicated by a healthcare professional.